Table 1. Clinical characteristics and medication for patients with LN.

Patient	Age/Sex	Disease duration (months)	Anti-dsDNA	Scr (μmol/L)	24-hour urine protein (mg)	Medication
1	57/F	24	+	256	710	CTX, MMF, Pred
2	46/F	4	+	88	3441	MMF, HCQ
3	34/F	7	+	296.2	7127.5	MMF
4	20/F	6	+	78	4307	Pred, HCQ
5	59/F	10	+	146	5002	Belimumab

Anti-dsDNAantidouble-stranded DNACTXcyclophosphamideHCQhydroxychloroquineMMFmycophenolate mofetilPredprednisoneScrserum creatinine